The most recent short interest data was recently released for the 04/15/2019 settlement date, and Heron Therapeutics Inc (NASDAQ:HRTX) is one of the most shorted stocks of the Russell 3000, based on 16.55 "days to cover" versus the median component at 5.30. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then divided by the average daily volume, to express the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
In the case of Heron Therapeutics Inc (NASDAQ:HRTX), the total short interest at the 04/15/2019 settlement date was 13,772,844 shares, which compares to the average daily trading volume of just 832,384 shares, for a "days to cover" ratio of 16.55.
When short sellers eventually cover their positions, by definition there must be buying activity because a share that is currently sold short must be purchased to be covered. At the present levels of short interest, if from this point forward every single HRTX share traded represented a short position being closed, then at the average daily volume of 832,384 shares it would only be during the 17th trading day that every short position would be closed.
So it would stand to reason that should some unexpectedly good news come out, and short sellers did not have 17 days of patience but instead wanted to cover their short positions very suddenly, that situation could result in sending the stock higher until the higher price produces enough sellers to generate the necessary volume to close out those positions quickly.
Heron Therapeutics Inc (NASDAQ:HRTX) has something relatively rare for a stock with this much short interest, that being insiders taking the other side of the trade. Looking back over the trailing six month period, HRTX has seen 2 different instances of insider buying, as summarized by the table below:
Below is a chart showing the "days to cover" for HRTX over time:
And looking at the chart below, HRTX's low point in its 52 week range is $15.68 per share, with $41.10 as the 52 week high point — that compares with a last trade of $18.31.
In recent trading, shares of Heron Therapeutics Inc (NASDAQ:HRTX) were changing hands at $18.31/share.
This Article's Word Cloud:DirectorHRTXHeronTherapeuticsaveragebecausebeingbelowbuyingchartcloseclosedcomparescoverdailydatadatedayseveryfillColorhigherinterestmostmustnumberoverperiodpointpositionpositionsrecentrepresentedsellerssettlementsharesharesshortstockthattheirthenthistotaltradetradedtradingvolumeweekwithwould
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.